Wachtell, Lipton, Rosen & Katz and Willkie Farr & Gallagher advised Constellation on the deal. Goodwin Procter, Dechert and Maiwald acted as legal advisors to Royalty...
MorphoSys’ $1.7 Billion Acquisition of Constellation Pharmaceuticals
Royalty Pharmaìs Acquisition of Royalty Interest from GSK
Dechert advised Royalty Pharma on the deal. Royalty Pharma plc executed its acquisition of a royalty interest in the cabozantinib products Cabometyx and Cometriq from GlaxoSmithKline...